Fcγ receptor–mediated cross-linking codefines the immunostimulatory activity of anti-human CD96 antibodies
New strategies that augment T cell responses are required to broaden the therapeutic arsenal against cancer. CD96, TIGIT, and CD226 are receptors that bind to a communal ligand, CD155, and transduce either inhibitory or activating signals. The function of TIGIT and CD226 is established, whereas the...
| প্রধান লেখক: | , , , , , , , , |
|---|---|
| বিন্যাস: | প্রবন্ধ |
| ভাষা: | English |
| প্রকাশিত: |
American Society for Clinical investigation
2022-10-01
|
| মালা: | JCI Insight |
| বিষয়গুলি: | |
| অনলাইন ব্যবহার করুন: | https://doi.org/10.1172/jci.insight.158444 |